Shikonin derivative DMAKO-05inhibits Akt signal activation and melanoma proliferation.
Shikonin derivative DMAKO-05inhibits Akt signal activation and melanoma proliferation.
复制标题
紫草素衍生物 DMAKO-05 抑制 Akt 信号激活和黑色素瘤增殖
DOI:
10.1111/cbdd.12722
复制
发表时间:
2016
影响因子:
3
通讯作者:
Feng Qian
中科院分区:
文献类型:
--
作者:
Yao-yao Yang;Hui-qiong He;Jia-hua Cui;Yun-juan Nie;Ya-xian Wu;Rui Wang;Richard D. Ye;Qiong Wu;Shao-shun Li;Feng Qian
DMAKO‐05((S)‐1‐((5E,8E)‐5,8‐bis(hydroxyimino)‐1,4‐dimethoxy‐5,8‐dihydronaphthalen‐2‐yl)‐4‐methylpent‐3‐enyl 3‐methylbutanoate) is a novel oxime derivative of shikonin, the major component extracted from Chinese herbLithospermun erythrorhizon. Here, we report that DMAKO‐05 had an antitumor activity against mouse melanoma cell line B16F0. Our studies indicated that DMAKO‐05 not only inhibited B16F0 proliferation and migration but also led to cell cycle arrest at G1 phase and cell apoptosis, in which DMAKO‐05 triggered mitochondrial‐mediated apoptosis signal including caspase‐9/3 and PARP. In response to DMAKO‐05 treatment, the Akt‐mediated survival signals were remarkably attenuated in B16F0 cells. Collectively, DMAKO‐05 has a strong cytotoxicity in B16F0 cells via inhibiting Akt activation, inducing G1 arrest, and promoting B16F0 cell apoptosis. DMAKO‐05 might serve as a potential candidate lead compound for melanoma.